Systemic immunity in cancer | Nature Reviews Cancer
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment | Cellular & Molecular Immunology
Correlating total mutational burden with response to PD-1/L1 blockade... | Download Scientific Diagram
Targeting immunosuppressive adenosine in cancer | Nature Reviews Cancer
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making - Hellemans - 2021 - Transplant International -
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy - ScienceDirect
Patient-centred approaches for the management of unpleasant symptoms in kidney disease | Nature Reviews Nephrology
Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities | Aging
Immunotherapy combined with radiotherapy to reverse immunosuppression in microsatellite stable colorectal cancer | SpringerLink
Clinical use of dendritic cells for cancer therapy - The Lancet Oncology
Frontiers | Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
ER Stress Regulates Immunosuppressive Function of Myeloid Derived Suppressor Cells in Leprosy that Can Be Overcome in the Presence of IFN-γ - ScienceDirect
Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer
Frontiers | Immunotherapy for Glioblastoma: Current Progress and Challenges
Cancer Risk Among Immunosuppressed Populations - NCI
Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
Frontiers | Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
IJMS | Free Full-Text | The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect
Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
